Treating rheumatoid arthritis early: A window of opportunity?

Arthritis and Rheumatism

Volumn 46, Issue 2, 2002, Pages 283-285

  O'Dell, James R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

DISEASE COURSE; DRUG TOLERABILITY; EDITORIAL; HUMAN; INFLAMMATION; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS;

EID: 0036166461     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10092     Document Type: Editorial

References (20)

1. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5-Year followup of a prospective double blind placebo controlled study
2. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: A 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study
3. The effectiveness of early treatment with "second-line" antirheumatic drugs: A randomized, controlled trial
4. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications
5. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
6. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial
7. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis
8. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis
9. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
10. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
11. The effect of glucocorticoids on joint destruction in rheumatoid arthritis
12. Long-term mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well
13. Joint erosions and patients with early rheumatoid arthritis
14. The majority of patients with rheumatoid arthritis have erosive disease at presentation when magnetic resonance imaging of the dominant hand is employed
15. COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention
16. Remodeling the pyramid: A concept whose time has come
17. Rheumatoid arthritis: Not yet curable with early intensive therapy
18. Preliminary definition of improvement in rheumatoid arthritis
19. Enbrel® (etanercept) vs methotrexate (MTX) in early rheumatoid arthritis (ERA trial): Two-year follow-up
20. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis